NT

Naveena Tirumanagiri

Active Director Director DIN 09323421
DIN 09323421 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Naveena Tirumanagiri

Data last updated:

Naveena Tirumanagiri is a Director at Kirthy Pharmachem Private Limited (since 2021). The company operates in Pharma. Kirthy Pharmachem Private Limited reported revenue of ₹1.4 Lakh (FY 2024).

DIN 09323421
Primary Designation Director
Industry Pharma
First Appointment 17 Sep 2021
Oldest Company Age 5 yrs
Largest company Kirthy Pharmachem Private Limited · ₹1.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kirthy Pharmachem Private Limited U24100TG2021PTC155034
Director17 Sep 20212021₹1.4 Lakh (FY 2024)Active

Board colleagues of Naveena Tirumanagiri

Directorship timeline

Open interactive timeline →
Kirthy Pharmachem Private Limited
Premium access

Shareholding and investment profile for Naveena Tirumanagiri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveena Tirumanagiri

Naveena Tirumanagiri currently holds 1 directorship: Kirthy Pharmachem Private Limited (Director, since 17 Sep 2021, revenue ₹1.4 Lakh (FY 2024)).

Naveena Tirumanagiri was first appointed on 17 Sep 2021 as Director at Kirthy Pharmachem Private Limited.

The current boards of Naveena Tirumanagiri's companies include Maroji Narsimha Chary (Kirthy Pharmachem Private Limited), Tumma Balakrishna Kumar (Kirthy Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available